publication venue for
- Predictive value of the respiratory syncytial virus risk-scoring tool in the term infant in Canada 2009
- Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects 2006
- A prospective cohort study of chronic postsurgical pain after ambulatory surgeries. 40:1187-1193. 2024
- Adoption in Canada of an international risk scoring tool to predict respiratory syncytial virus hospitalization in moderate-to-late preterm infants. 37:1149-1153. 2021
- Tool to assess causality of direct and indirect adverse events associated with therapeutic interventions. 34:407-414. 2018
- A post-marketing assessment of major bleeding in total hip and total knee replacement surgery patients receiving rivaroxaban. 33:1717-1723. 2017
- Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing. 31:2031-2042. 2015
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program. 31:1391-1401. 2015
- Corrigendum. 29:1211-1211. 2013
- Venous thromboembolism management: where do novel anticoagulants fit?. 29:783-790. 2013
- How to define responders in osteoarthritis. 29:719-729. 2013
- Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. 29:205-216. 2013
- Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck. 27:2253-2259. 2011
- In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada. 27:1749-1754. 2011
- Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?. 26:1139-1140. 2010
- Comment on: Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Reply. 26:1140-1140. 2010
- Erratum. 26:990-990. 2010
- Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA. 26:599-604. 2010
- Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?. 25:2021-2041. 2009
- Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis. 25:1631-1633. 2009
- Comment and reply on: The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32-35 weeks: a Canadian-based analysis Reply. 25:1632-1633. 2009
- Risk-Scoring Tool for respiratory syncytial virus prophylaxis in premature infants born at 33–35 completed weeks’ gestational age in Canada. 25:1585-1591. 2009
- Effectiveness of a trandolapril-based treatment regimen in subjects with isolated systolic hypertension in Canada. 25:1379-1384. 2009
- Limitations of statin monotherapy for the treatment of dyslipidemia: a projection based on the Canadian lipid study – observational. 25:47-55. 2009
- The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis. 24:3223-3237. 2008
- Transferability of economic evaluations: approaches and factors to consider when using results from one geographic area for another. 23:671-682. 2007
- Cost-effectiveness of alternative treatments for women with osteoporosis in Canada. 22:1425-1436. 2006
- Does the treatment of gastroesophageal reflux disease (GERD) meet patients’ needs? A survey‐based study. 22:657-662. 2006
- The economic burden of schizophrenia in Canada in 2004. 21:2017-2028. 2005
- Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey – phase IV*. 20:1777-1783. 2004
- Correction to: E. A. MacGregor, J. Brandes, A. Eikermann and R. Giammarco. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey - Phase III. Curr Med Res Opin 2004; 20(7): 1143-1150.. 20:1689-1690. 2004
- Correction to: J. Zacher, D. Feldman, R. Gerli et al. A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Curr Med Res Opin 2003; 19(8): 725-736.. 20:1689-1690. 2004
- Nursing home-acquired pneumonia: an emergency department treatment algorithm. 20:1309-1320. 2004
- Comment on Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis. 20:1161-1163. 2004
- Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey – Phase III. 20:1143-1150. 2004
- Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudine. 20:1115-1123. 2004
- Triple nucleoside treatment with abacavir plus the lamivudine/ zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014). 20:1103-1114. 2004
- The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repair. 20:903-910. 2004
- Efficacy of risedronate on clinical vertebral fractures within six months. 20:433-439. 2004
- A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. 19:725-736. 2003
- Clinical experience of galantamine in dementia: a series of case reports. 19:508-518. 2003
- The pharmacokinetics of isoxicam in elderly patients with rheumatoid arthritis. 10:580-591. 1987
- Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. 10:89-93. 1986